胎儿的高缩性心肌病:一种罕见的呈现案例报告
Alireza Golbabaei1, Elham Sadat Alavi Moghaddam2, Mahsa Naemi3
1Department of Perinatology and Fetal Cardiology Shariati Hospital, Tehran University of Medical Sciences Tehran Iran.
Clinical case reports
|July 14, 2025
概括
胎儿缩性心肌病,一种导致阻塞的心脏病,在一个胎儿身上被诊断出. 出生后使用普拉诺洛尔的治疗导致新生儿的积极结果.
科学领域:
- 心脏病学 心脏病学
- 周围生理学 周围生理学
- 儿童心脏病学 儿童心脏病学
背景情况:
- 胎儿心壮病可能表明潜在的心脏异常.
- 超性心肌病症在子宫内具有严重的左心室外流通道阻塞的风险.
- 早期诊断和管理对于改善新生儿结果至关重要.
研究的目的:
- 报告一个胎儿高性心肌病病例与左心室外流通道阻塞.
- 描述诊断出这种情况的新生儿的管理和结果.
主要方法:
- 在产前诊断胎儿心脏病.
- 确认胎儿高性心肌病症与左心室外流通道阻塞.
- 在怀孕39周的阴道分娩.
- 产后使用普罗普兰诺洛的治疗.
主要成果:
- 新生儿成功分娩,并开始接受普罗普拉诺洛尔治疗.
- 婴儿在定期随访下表现出良好的临床进展.
- 在治疗后没有报告任何直接的并发症.
结论:
- 胎儿缩性心肌病与左心室外流通道阻塞是一种严重的疾病,需要专门的护理.
- 普罗普拉诺洛尔可以作为新生儿高性心肌病的有效治疗方法.
- 多学科的随访对于治疗先天性心脏病的婴儿至关重要.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
54
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
54
Cardiomyopathy II: Dilated Cardiomyopathy
24
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
24
Cardiomyopathy IV: Restrictive Cardiomyopathy
36
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
36
Cardiomyopathy I: Introduction and Classification
65
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
65
Teratogenicity
2.8K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K
Cardiomyopathy V: Interprofessional Care
37
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
37


